Best practices for laboratory informatics, scientific data management, ELN, LIMS and GxP
Pharmaceutical Stability Testing
Pharmaceutical stability testing
Pharmaceutical stability testing is a critical regulatory requirement in the drug development lifecycle, used to determine how the quality of a medicinal product changes over time under the influence of environmental factors such as temperature, humidity, and light exposure. It establishes the shelf life, recommended storage conditions and ongoing efficacy of a drug substance or product throughout its intended duration of use.
Key takeaways
- Regulatory compliance: Essential for New Drug Application (NDA) submissions and ICH guideline adherence.
- Quality assurance: Detects physical, chemical and microbiological changes over time.
- Shelf-life determination: Combines real-time and accelerated data to set expiration dates.
- Patient safety: Prevents the use of degraded or potentially toxic compounds.
- Data integrity: Requires robust informatics to manage complex, long-running datasets.
Stages of pharmaceutical stability testing
Stability testing is not a one-off event. It runs across the entire lifecycle of a therapeutic — from pre-formulation through commercial supply:
- Stress testing: Identifies degradation pathways and the intrinsic stability of the molecule.
- Accelerated testing: Uses elevated temperature and humidity to predict long-term changes.
- Long-term testing: Real-time monitoring of the product in its final packaging under recommended storage conditions.
- Intermediate testing: Triggered when significant changes are observed during accelerated testing.
Standard storage conditions (ICH guidelines)
The International Council for Harmonisation (ICH) sets standardized climatic conditions for pharmaceutical stability testing to ensure global consistency:
| Condition | Storage | Duration |
|---|---|---|
| Long-term | 25°C ± 2°C / 60% RH ± 5% | minimum 12 months |
| Intermediate | 30°C ± 2°C / 65% RH ± 5% | 6 months |
| Accelerated | 40°C ± 2°C / 75% RH ± 5% | 6 months |
Why stability testing is crucial for modern R&D
Stability testing is more than a regulatory box-tick. It provides the empirical evidence that a drug’s potency stays within specification — so a patient dosed today receives the same therapeutic benefit as one dosed months later. It also informs primary packaging decisions: whether glass vials, blister packs, or plastic containers offer adequate protection against moisture or light-induced degradation. Many organizations now use connected stability platforms to link these findings directly to manufacturing workflows.
Advanced analytical challenges
Modern biologics and complex small molecules present unique challenges. They are often highly sensitive to minor temperature fluctuations, and photostability testing requires precise light exposure to confirm the active pharmaceutical ingredient (API) doesn’t break down into new impurity profiles. Managing the volume of data generated by stability-indicating assays — which must be validated to detect degradation products amongst excipients — is a significant hurdle. A digital platform such as an electronic laboratory notebook (ELN) helps automate capture and reporting of these complex results.
Best practices for successful stability programs
Efficiency in stability testing hinges on digital maturity. Manual transcription of data from stability chambers into spreadsheets is a common compliance risk. Effective programs focus on:
- Automated environmental monitoring: Link stability chambers directly to data systems for real-time alerting.
- Standardized protocols: Uniform workflows for sample withdrawal, testing, and analysis.
- Lean sample management: Track pull dates precisely to avoid non-conformances in the testing schedule.
- Integrated quality systems: Connect stability data to broader Quality Management Systems (QMS) for streamlined reporting.
Digitizing these workflows shifts stability from reactive compliance to proactive lifecycle management — especially valuable for manufacturing, where historical stability data helps predict the performance of future commercial batches.
Bring stability studies under control with IDBS
Pharmaceutical stability testing generates value only when protocols, pull schedules, and results stay aligned across months — or years — of execution. See how the IDBS Polar Stability application orchestrates stability from protocol to pull in one connected workflow, and read our related blog Why Stability Studies Slip — and How to Regain Control for a closer look at where control typically breaks down.
Frequently asked questions
What is a “significant change” in stability testing?
A significant change is defined as a 5% change in assay from the initial value, or any failure to meet specifications for appearance, physical attributes, or pH. Where such a change occurs during accelerated testing, intermediate testing must be initiated.
How is “bracketing” used in stability studies?
Bracketing is a design strategy where only samples at the extremes of certain design factors (e.g., strength or container size) are tested at all timepoints. It assumes intermediate levels behave in line with the extremes, significantly reducing the testing burden.
Can pharmaceutical stability testing be performed on drug substances alone?
No. Stability testing must cover both the drug substance (API) and the drug product (finished formulation), ensuring that interaction between the active ingredient and excipients does not compromise safety or efficacy.
What role does light exposure play in stability?
Photostability testing is a requirement for many therapeutics. It exposes the product to visible and ultraviolet light to determine whether it is “light-labile.” If significant degradation occurs, opaque or amber packaging is used to protect the formulation.
What is the difference between shelf life and retest period?
Shelf life (or expiry date) applies to the finished drug product, indicating how long it remains fit for use. A retest period applies to the drug substance (API), indicating the point at which it must be re-evaluated before further manufacturing use.
Looking to streamline your stability studies and improve data management? Explore IDBS Application Stability to learn how connected workflows can help accelerate insights and support compliance. Learn more.
